Allarity Acquisition Corp. Form S-1/A — Oct 9, 2026
Allarity Acquisition Corp., a Cayman Islands blank check company sponsored by a subsidiary of Allarity Therapeutics (ALLR), filed an S-1/A for an $80 million IPO of 8 million units at $10.00 each, each unit comprising one Class A share and one warrant with an $11.50 exercise price. Maxim Group LLC is sole book-running manager, with a 45-day option on up to 1.2 million additional units. The sponsor will buy 2.5 million private warrants for $2.5 million and purchased 3,833,333 founder shares for $25,000 (~$0.0065/share), entitling insiders to 25% of post-IPO shares, with substantial anti-dilution protections.
Key figures
- Gross Proceeds
- 80000000
- Offering Price
- 10
- Shares Offered
- 8,000,000 units at $10.00 per unit
- Sponsor Loan
- up to $300,000
- Trust Deposit
- $80,800,000 (or $92,920,000 with full over-allotment)
- Founder Shares
- 3,833,333 Class B shares purchased for $25,000 (~$0.0065/share)
- Private Warrants
- 2,500,000 at $1.00 ($2,500,000)
- Completion Window
- 15 months from closing
- Over Allotment Option
- 1,200,000 units
- Underwriting Discount
- $0.05 per unit / $400,000 total
- Warrant Exercise Price
- $11.50 per share
- Working Capital Loan Conversion
- up to $1,500,000 convertible into warrants at $1.00
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.